5owp: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
m Protected "5owp" [edit=sysop:move=sysop]
OCA (talk | contribs)
No edit summary
 
(4 intermediate revisions by the same user not shown)
Line 1: Line 1:
'''Unreleased structure'''


The entry 5owp is ON HOLD
==Crystal structure of glycopeptide "GVTSAfPDT*RPAP" in complex with scFv-SM3==
<StructureSection load='5owp' size='340' side='right'caption='[[5owp]], [[Resolution|resolution]] 1.85&Aring;' scene=''>
== Structural highlights ==
<table><tr><td colspan='2'>[[5owp]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Mus_musculus Mus musculus] and [https://en.wikipedia.org/wiki/Synthetic_construct Synthetic construct]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5OWP OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5OWP FirstGlance]. <br>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.85&#8491;</td></tr>
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=4FB:(4S)-4-FLUORO-L-PROLINE'>4FB</scene>, <scene name='pdbligand=A2G:N-ACETYL-2-DEOXY-2-AMINO-GALACTOSE'>A2G</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5owp FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5owp OCA], [https://pdbe.org/5owp PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5owp RCSB], [https://www.ebi.ac.uk/pdbsum/5owp PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5owp ProSAT]</span></td></tr>
</table>
== Function ==
[https://www.uniprot.org/uniprot/LV1D_MOUSE LV1D_MOUSE] [https://www.uniprot.org/uniprot/HVM32_MOUSE HVM32_MOUSE]
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
A structure-based design of a new generation of tumor-associated glycopeptides with improved affinity against two anti-MUC1 antibodies is described. These unique antigens feature a fluorinated proline residue, such as a (4S)-4-fluoro-l-proline or 4,4-difluoro-l-proline, at the most immunogenic domain. Binding assays using biolayer interferometry reveal 3-fold to 10-fold affinity improvement with respect to the natural (glyco)peptides. According to X-ray crystallography and MD simulations, the fluorinated residues stabilize the antigen-antibody complex by enhancing key CH/pi interactions. Interestingly, a notable improvement in detection of cancer-associated anti-MUC1 antibodies from serum of patients with prostate cancer is achieved with the non-natural antigens, which proves that these derivatives can be considered better diagnostic tools than the natural antigen for prostate cancer.


Authors: Bermejo, I.A., Albuquerque, I.S., Somovilla, V.J., Martinez-Saez, N., Castro-Lopez, J., Garcia-Martin, F., Hinou, H., Nishimura, S., Jimenez-Barbero, J., Asensio, J.L., Avenoza, A., Busto, J.H., Hurtado-Guerrero, R., Peregrina, J.M., Bernardes, G.J., Corzana, F.
The Use of Fluoroproline in MUC1 Antigen Enables Efficient Detection of Antibodies in Patients with Prostate Cancer.,Somovilla VJ, Bermejo IA, Albuquerque IS, Martinez-Saez N, Castro-Lopez J, Garcia-Martin F, Companon I, Hinou H, Nishimura SI, Jimenez-Barbero J, Asensio JL, Avenoza A, Busto JH, Hurtado-Guerrero R, Peregrina JM, Bernardes GJL, Corzana F J Am Chem Soc. 2017 Dec 12. doi: 10.1021/jacs.7b09447. PMID:29166012<ref>PMID:29166012</ref>


Description: Crystal structure of glycopeptide ""GVTSAfPDT*RPAP"" in complex with scFv-SM3
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
[[Category: Unreleased Structures]]
</div>
[[Category: Asensio, J.L]]
<div class="pdbe-citations 5owp" style="background-color:#fffaf0;"></div>
[[Category: Garcia-Martin, F]]
 
[[Category: Martinez-Saez, N]]
==See Also==
[[Category: Bernardes, G.J]]
*[[Antibody 3D structures|Antibody 3D structures]]
[[Category: Hinou, H]]
*[[Monoclonal Antibodies 3D structures|Monoclonal Antibodies 3D structures]]
[[Category: Busto, J.H]]
*[[3D structures of non-human antibody|3D structures of non-human antibody]]
[[Category: Somovilla, V.J]]
== References ==
[[Category: Castro-Lopez, J]]
<references/>
[[Category: Peregrina, J.M]]
__TOC__
[[Category: Avenoza, A]]
</StructureSection>
[[Category: Jimenez-Barbero, J]]
[[Category: Large Structures]]
[[Category: Hurtado-Guerrero, R]]
[[Category: Mus musculus]]
[[Category: Albuquerque, I.S]]
[[Category: Synthetic construct]]
[[Category: Bermejo, I.A]]
[[Category: Albuquerque IS]]
[[Category: Corzana, F]]
[[Category: Asensio JL]]
[[Category: Nishimura, S]]
[[Category: Avenoza A]]
[[Category: Bermejo IA]]
[[Category: Bernardes GJ]]
[[Category: Busto JH]]
[[Category: Castro-Lopez J]]
[[Category: Corzana F]]
[[Category: Garcia-Martin F]]
[[Category: Hinou H]]
[[Category: Hurtado-Guerrero R]]
[[Category: Jimenez-Barbero J]]
[[Category: Martinez-Saez N]]
[[Category: Nishimura S]]
[[Category: Peregrina JM]]
[[Category: Somovilla VJ]]

Latest revision as of 01:26, 28 December 2023

Crystal structure of glycopeptide "GVTSAfPDT*RPAP" in complex with scFv-SM3

5owp, resolution 1.85Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA